Ten Years to Dapagliflozin Metformin FDC Approval in India - 10 Key Points to Revisit Written By Dr Tata Sameer Nandan12 Sept 2026 10:15 AM ISTType 2 diabetes mellitus (T2DM) affects an estimated 589 million adults globally, with India accounting for nearly 89.8 million cases, making early...
Cardiovascular Risk Management in T2D with established ASCVD: Current Evidence for Dapagliflozin and Sitagliptin-Dr Piyas Gargari Written By Dr. Piyas Gargari5 Aug 2026 10:43 AM ISTType 2 diabetes (T2D) frequently presents with cardiovascular complications already established, with cardiovascular diseases (CVD) accounting for...
Duodenal-Jejunal Bypass Liners Improve Diabetes Control but Raise Safety Concerns, Suggests Research Written By Medha Baranwal27 July 2026 9:00 PM ISTUSA: It has been found in a recent study that duodenal-jejunal bypass liners were more effective than sham treatment in reducing HbA1c and promoting...
Higher Ultra-Processed Food Intake Associated With Poorer Glycemic Control in Type 2 Diabetes: Study Written By Dr Riya Dave14 July 2026 9:45 AM ISTHigher consumption of ultra-processed foods (UPFs), assessed using a brief validated screening tool, was independently associated with poorer...
Saroglitazar Improves Multiple Metabolic Outcomes in Type 2 Diabetes: Study Finds Written By Medha Baranwal7 July 2026 9:45 AM ISTIndia: A new study among patients with type 2 diabetes and dyslipidemia revealed that treatment with saroglitazar 4 mg for six months significantly...
GLP-1 Receptor Agonists Protect Kidneys and Reduce Mortality in CKD: Study Written By Medha Baranwal23 Jun 2026 8:00 PM ISTUSA: A secondary analysis of the FLOW trial found that glucagon-like peptide-1 (GLP-1) receptor agonist therapy significantly reduced kidney-related...
From Monotherapy to Multi-Drug Regimens: Metformin's Role as the Therapeutic Backbone for Over Seven Decades Written By Dr. RITESH KU. AGRAWALA12 Jun 2026 10:41 AM ISTFor over seven decades, metformin has remained the cornerstone of T2DM management as monotherapy and in combination with other glucose-lowering...
Triple Metformin, SGLT-2, DPP-4 Therapy Outperforms Dual Therapy in T2DM: Study Written By Dr Kartikeya Kohli5 Jun 2026 10:00 AM ISTPakistan: Triple therapy combining metformin, SGLT-2 inhibitors, and DPP-4 inhibitors achieves superior glycemic control compared with...
Multi-Strain Probiotics Reduce Postprandial Blood Glucose in Type 2 Diabetes: Study Written By Dr Kartikeya Kohli29 May 2026 9:30 AM ISTThree months of multi-strain probiotic supplementation significantly reduced postprandial blood glucose (PPBG) levels in patients with type 2...
Higher Vegetable Intake Linked to Lower Diabetes Risk: Study Written By Dr Kartikeya Kohli28 May 2026 9:45 AM ISTResearchers have discovered in a new cross-sectional study that higher vegetable consumption was associated with a lower risk of diabetes,...
Depression may Worsen Glycemic Control in Type 2 Diabetes, reveals meta-analysis Written By Dr. Aashi verma22 May 2026 8:30 PM ISTA recent meta-analysis highlights that comorbid depression in type 2 diabetes mellitus is associated with a significant 0.30% increase in glycated...
SGLT2i Use Associated with Reduced Risk of Late-Onset Epilepsy: Study Written By Dr Riya Dave11 May 2026 10:00 AM ISTA large cohort study has shown that sodium-glucose cotransporter 2 inhibitor (SGLT2i) treatment is significantly associated with a decreased risk of...
